Roche
HealthSwiss drugmaker Roche leans into Trump tariff formula with $50 billion promise to invest in U.S.
By Ryan HoggApril 22, 2025
By Paula Doenecke, Naomi Kresge and BloombergMarch 12, 2025
By Lindsey LeakeFebruary 6, 2025
By Lindsey LeakeJanuary 21, 2025
By Naomi Kresge and BloombergSeptember 12, 2024
FinanceSwiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss
By Prarthana PrakashJuly 29, 2024
RetailAn obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche’s market value
By Naomi Kresge, Lisa Pham and BloombergJuly 23, 2024
FinanceSwitzerland shouldn’t follow Europe’s lead on tax, says Roche CEO. Instead, it must compete with ‘Dubai, China and India’
By Paula Doenecke and BloombergMay 14, 2024
SuccessMajor investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
By Ryan HoggApril 10, 2024
FinanceMeet Europe’s answer to the ‘Magnificent 7’—the high-flying ‘Granolas’ that Goldman Sachs is betting will prosper in the continent’s flatlining economy
By Ryan HoggMarch 3, 2024
FinanceRoche pushes to catch up to Novo Nordisk’s Wegovy with $3.1bn deal for obesity drugmaker Carmot
By Paula Doenecke and BloombergDecember 4, 2023
HealthRoche is using AI to find the hardest-to-find lung cancer patients, with a potential blockbuster drug on the line
By Naomi Kresge and BloombergOctober 22, 2023
HealthWhy a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
By Angel Adegbesan and BloombergOctober 13, 2023
By Sophie MellorJune 20, 2022
Most Popular
